NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
34.81
+0.87 (2.56%)
At close: Jan 22, 2026, 4:00 PM EST
34.30
-0.51 (-1.47%)
After-hours: Jan 22, 2026, 6:40 PM EST
NAMS Analyst Ratings
Total Analysts
9
Consensus Rating
Strong Buy
Price Target
$46.56
Upside
+33.75%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $44 → $47 | Buy | Maintains | $44 → $47 | +35.02% | Jan 21, 2026 |
| Stifel | Stifel | Strong Buy Maintains $44 → $50 | Strong Buy | Maintains | $44 → $50 | +43.64% | Dec 16, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $30 → $37 | Hold | Maintains | $30 → $37 | +6.29% | Dec 2, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $39 → $44 | Buy | Maintains | $39 → $44 | +26.40% | Nov 6, 2025 |
| Needham | Needham | Strong Buy Maintains $40 → $46 | Strong Buy | Maintains | $40 → $46 | +32.15% | Nov 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $52 | Strong Buy | Initiates | $52 | +49.38% | Oct 20, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $42 → $50 | Strong Buy | Maintains | $42 → $50 | +43.64% | Oct 17, 2025 |
| Wells Fargo | Wells Fargo | Buy Initiates $45 | Buy | Initiates | $45 | +29.27% | Aug 25, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $38 → $39 | Buy | Maintains | $38 → $39 | +12.04% | Aug 7, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Initiates $27 | Hold | Initiates | $27 | -22.44% | Jul 17, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $42 | Strong Buy | Initiates | $42 | +20.65% | Jun 17, 2025 |
| Needham | Needham | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +14.91% | Jun 12, 2025 |
| Stifel | Stifel | Strong Buy Initiates $44 | Strong Buy | Initiates | $44 | +26.40% | Jun 10, 2025 |
| Needham | Needham | Strong Buy Maintains $42 → $40 | Strong Buy | Maintains | $42 → $40 | +14.91% | May 8, 2025 |
| Needham | Needham | Strong Buy Reiterates $42 | Strong Buy | Reiterates | $42 | +20.65% | Apr 8, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $47 → $52 | Buy | Maintains | $47 → $52 | +49.38% | Feb 27, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.